Q2 2026 · Form 13F LedgerData source: SEC EDGAR  
H

HOLDER.TOP

Who owns what — the quarterly ledger of U.S. institutional holdings.
EN · 简 · 繁
Funds / Sectoral Asset Management Inc
Form 13F · Q2 2026

Sectoral Asset Management Inc

CIK 1274413Filed 2026-08-1413F-HR View the filing on EDGAR ↗
$143M
Reported book value
82
Positions
12
Quarters on record
Top 50
Positions

Sectoral Asset Management Inc — holdings

Top 50 positions of 82, ranked by reported value. Share change is versus the previous quarter.
#SecuritySharesShare Δ QoQValue% of book
1CTNM Contineum Therapeutics Inc727,587+0.0%$12M8.3%
2SI Shoulder Innovations Inc430,407+0.0%$9M6.1%
3LLY Eli Lilly & Co6,354+0.0%$8M5.3%
4UNH Unitedhealth Group Inc13,235−11.5%$6M3.8%
5JNJ Johnson & Johnson18,218+0.0%$5M3.2%
6ORKA Oruka Therapeutics Inc41,987—$4M2.8%
7BNTX Biontech Se41,869+88.9%$4M2.7%
8DFTX Definium Therapeutics Inc78,310—$4M2.6%
9DXCM Dexcom Inc50,756+118.5%$3M2.4%
10RCUS Arcus Biosciences Inc110,870+146.0%$3M2.4%
11AMGN Amgen Inc9,210+0.0%$3M2.3%
12SMMT Summit Therapeutics Inc220,180+216.3%$3M2.2%
13IRTC Irhythm Holdings Inc26,070—$3M2.2%
14ABBV Abbvie Inc12,200+0.0%$3M2.1%
15MRK Merck & Co Inc21,480+0.0%$3M1.9%
16AVBP Arrivent Biopharma Inc79,043+163.4%$3M1.9%
17VERTEX PHARMACEUTICALS INC Vertex Pharmaceuticals Inc5,432−22.5%$3M1.9%
18ARGX Argenx Se2,831−20.6%$3M1.8%
19GILD Gilead Sciences Inc20,620−25.0%$3M1.8%
20INSM Insmed Inc23,216+18.0%$2M1.7%
21TECX Tectonic Therapeutic Inc71,009+272.6%$2M1.7%
22ISRG Intuitive Surgical Inc5,850+11.4%$2M1.6%
23IMTX Immatics N.V224,928+236.6%$2M1.6%
24SYK Stryker Corporation7,129+21.4%$2M1.6%
25AVTX Avalo Therapeutics Inc119,923—$2M1.5%
26CBIO Crescent Biopharma Inc.121,300—$2M1.5%
27ROIV Roivant Sciences Ltd61,100+88.0%$2M1.5%
28IQV Iqvia Hldgs Inc10,848+30.6%$2M1.5%
29PLSE Pulse Biosciences Inc67,895—$2M1.3%
30DANAHER CORP DEL Danaher Corp Del9,597+0.0%$2M1.3%
31TMO Thermo Fisher Scientific Inc3,508+0.0%$2M1.2%
32ABT Abbott Laboratories18,080−29.3%$2M1.1%
33ATEC Alphatec Hldgs Inc185,900—$2M1.1%
34BSX Boston Scientific Corp36,330+4.5%$2M1.1%
35TMDX Transmedics Group Inc21,950—$1M1.0%
36CYTK Cytokinetics Inc16,330+123.7%$1M1.0%
37REGN Regeneron Pharmaceuticals2,169−25.7%$1M0.9%
38CVS Cvs Health Corp13,000—$1M0.9%
39EW Edwards Lifesciences Corp14,826−14.5%$1M0.9%
40TRVI Trevi Therapeutics Inc65,596−11.9%$1M0.9%
41BMY Bristol-Myers Squibb Co21,150+0.0%$1M0.9%
42VERA Vera Therapeutics Inc25,573+0.0%$1M0.8%
43COGT Cogent Biosciences Inc26,740+20.8%$1M0.7%
44MDT Medtronic Plc11,100+0.0%$876,3450.6%
45TARS Tarsus Pharmaceuticals Inc13,285+17.9%$836,1580.6%
46KURA Kura Oncology Inc71,480+0.0%$784,1360.5%
47CNC Centene Corp Del12,000—$770,2800.5%
48UTHR United Therapeutics Corp Del1,370−19.9%$742,3070.5%
49HNGE Hinge Health Inc8,744−28.6%$725,7520.5%
50NKTR Nektar Therapeutics10,111−6.8%$705,8490.5%
Source: Form 13F filings via SEC EDGAR. Positions as of Jun 30, 2026. Options (put/call) are excluded from share counts.